Lithium chloride induces mesenchymal-to-epithelial reverting transition in primary colon cancer cell cultures

Valeria Costabile, Francesca Duraturo, Paolo Delrio, Daniela Rega, Ugo Pace, Raffaella Liccardo, Giovanni Battista Rosi, Rita Genesio, Lucio Nitsch, Paola Izzo, Marina De Rosa

Research output: Contribution to journalArticle

Abstract

Epithelial-to-mesenchymal transition (EMT) confers stem cell-like phenotype and more motile properties to carcinoma cells. During EMT, the expression of E-cadherin decreases, resulting in loss of cell-cell adhesion and increased migration. Expression of Twist1 and other pleiotropic transcription factors, such as Snail, is known to activate EMT. We established primary colon cancer cell cultures from samples of operated patients and validated cultures by cytogenetic and molecular biology approaches. Western blot assay, quantitative real-time PCR and immunofluorescence were performed to investigate the expression of E-cadherin, vimentin, β-catenin, cytokeratin-20 and -18, Twist1, Snail, CD44, cyclooxygenase-2 (COX2), Sox2, Oct4 and Nanog. Moreover, cell differentiation was induced by incubation with LiCl-containing medium for 10 days. We observed that these primary colorectal cancer (CRC) cells lost expression of the E-cadherin epithelial marker, which was instead expressed in cancer and normal colon mucosa of the same patient, while overexpressed vimentin (mesenchymal marker), Twist1, Snail (EMT markers) and COX2. Cytokeratin-18 was expressed both in tissues and cell cultures. Expression of stem cell markers, such as CD44, Oct4 and Nanog, were also observed. Following differentiation with the glycogen synthase kinase 3β (GSK3β) inhibitor LiCl, the cells began to express E-cadherin and, at once, Twist1 and Snail expression was strongly downregulated, suggesting a MET-reverting process. In conclusion, we established primary colon mesenchymal cancer cell cultures expressing mesenchymal and epithelial biomarkers together with high level of EMT transcription factors. We propose that they could represent a good model for studying EMT and its reverting mechanism, the mesenchymal-to-epithelial transition (MET). Our observation indicates that LiCl, a GSK3β inhibitor, induces MET in vitro, suggesting that LiCl and GSK3β could represent, respectively, interesting drug, and target for CRC therapy.

Original languageEnglish
Pages (from-to)1913-1923
Number of pages11
JournalInternational Journal of Oncology
Volume46
Issue number5
DOIs
Publication statusPublished - May 1 2015

Fingerprint

Lithium Chloride
Epithelial-Mesenchymal Transition
Colonic Neoplasms
Cell Culture Techniques
Cadherins
Glycogen Synthase Kinase 3
Keratin-18
Vimentin
Cyclooxygenase 2
Colorectal Neoplasms
Transcription Factors
Stem Cells
Keratin-20
Catenins
Snails
Cell Adhesion
Cytogenetics
Fluorescent Antibody Technique
Real-Time Polymerase Chain Reaction
Molecular Biology

Keywords

  • Colorectal cancer
  • Epithelial-to-mesenchymal transition
  • GSK3β inhibition
  • Mesenchymal-to-epithelial transition
  • Primary colon cancer cell cultures
  • Stem cell-like phenotype

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Lithium chloride induces mesenchymal-to-epithelial reverting transition in primary colon cancer cell cultures. / Costabile, Valeria; Duraturo, Francesca; Delrio, Paolo; Rega, Daniela; Pace, Ugo; Liccardo, Raffaella; Rosi, Giovanni Battista; Genesio, Rita; Nitsch, Lucio; Izzo, Paola; De Rosa, Marina.

In: International Journal of Oncology, Vol. 46, No. 5, 01.05.2015, p. 1913-1923.

Research output: Contribution to journalArticle

Costabile, Valeria ; Duraturo, Francesca ; Delrio, Paolo ; Rega, Daniela ; Pace, Ugo ; Liccardo, Raffaella ; Rosi, Giovanni Battista ; Genesio, Rita ; Nitsch, Lucio ; Izzo, Paola ; De Rosa, Marina. / Lithium chloride induces mesenchymal-to-epithelial reverting transition in primary colon cancer cell cultures. In: International Journal of Oncology. 2015 ; Vol. 46, No. 5. pp. 1913-1923.
@article{d52bf41a0b5a4a64bdc49f1549d0316d,
title = "Lithium chloride induces mesenchymal-to-epithelial reverting transition in primary colon cancer cell cultures",
abstract = "Epithelial-to-mesenchymal transition (EMT) confers stem cell-like phenotype and more motile properties to carcinoma cells. During EMT, the expression of E-cadherin decreases, resulting in loss of cell-cell adhesion and increased migration. Expression of Twist1 and other pleiotropic transcription factors, such as Snail, is known to activate EMT. We established primary colon cancer cell cultures from samples of operated patients and validated cultures by cytogenetic and molecular biology approaches. Western blot assay, quantitative real-time PCR and immunofluorescence were performed to investigate the expression of E-cadherin, vimentin, β-catenin, cytokeratin-20 and -18, Twist1, Snail, CD44, cyclooxygenase-2 (COX2), Sox2, Oct4 and Nanog. Moreover, cell differentiation was induced by incubation with LiCl-containing medium for 10 days. We observed that these primary colorectal cancer (CRC) cells lost expression of the E-cadherin epithelial marker, which was instead expressed in cancer and normal colon mucosa of the same patient, while overexpressed vimentin (mesenchymal marker), Twist1, Snail (EMT markers) and COX2. Cytokeratin-18 was expressed both in tissues and cell cultures. Expression of stem cell markers, such as CD44, Oct4 and Nanog, were also observed. Following differentiation with the glycogen synthase kinase 3β (GSK3β) inhibitor LiCl, the cells began to express E-cadherin and, at once, Twist1 and Snail expression was strongly downregulated, suggesting a MET-reverting process. In conclusion, we established primary colon mesenchymal cancer cell cultures expressing mesenchymal and epithelial biomarkers together with high level of EMT transcription factors. We propose that they could represent a good model for studying EMT and its reverting mechanism, the mesenchymal-to-epithelial transition (MET). Our observation indicates that LiCl, a GSK3β inhibitor, induces MET in vitro, suggesting that LiCl and GSK3β could represent, respectively, interesting drug, and target for CRC therapy.",
keywords = "Colorectal cancer, Epithelial-to-mesenchymal transition, GSK3β inhibition, Mesenchymal-to-epithelial transition, Primary colon cancer cell cultures, Stem cell-like phenotype",
author = "Valeria Costabile and Francesca Duraturo and Paolo Delrio and Daniela Rega and Ugo Pace and Raffaella Liccardo and Rosi, {Giovanni Battista} and Rita Genesio and Lucio Nitsch and Paola Izzo and {De Rosa}, Marina",
year = "2015",
month = "5",
day = "1",
doi = "10.3892/ijo.2015.291",
language = "English",
volume = "46",
pages = "1913--1923",
journal = "International Journal of Oncology",
issn = "1019-6439",
publisher = "Spandidos Publications",
number = "5",

}

TY - JOUR

T1 - Lithium chloride induces mesenchymal-to-epithelial reverting transition in primary colon cancer cell cultures

AU - Costabile, Valeria

AU - Duraturo, Francesca

AU - Delrio, Paolo

AU - Rega, Daniela

AU - Pace, Ugo

AU - Liccardo, Raffaella

AU - Rosi, Giovanni Battista

AU - Genesio, Rita

AU - Nitsch, Lucio

AU - Izzo, Paola

AU - De Rosa, Marina

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Epithelial-to-mesenchymal transition (EMT) confers stem cell-like phenotype and more motile properties to carcinoma cells. During EMT, the expression of E-cadherin decreases, resulting in loss of cell-cell adhesion and increased migration. Expression of Twist1 and other pleiotropic transcription factors, such as Snail, is known to activate EMT. We established primary colon cancer cell cultures from samples of operated patients and validated cultures by cytogenetic and molecular biology approaches. Western blot assay, quantitative real-time PCR and immunofluorescence were performed to investigate the expression of E-cadherin, vimentin, β-catenin, cytokeratin-20 and -18, Twist1, Snail, CD44, cyclooxygenase-2 (COX2), Sox2, Oct4 and Nanog. Moreover, cell differentiation was induced by incubation with LiCl-containing medium for 10 days. We observed that these primary colorectal cancer (CRC) cells lost expression of the E-cadherin epithelial marker, which was instead expressed in cancer and normal colon mucosa of the same patient, while overexpressed vimentin (mesenchymal marker), Twist1, Snail (EMT markers) and COX2. Cytokeratin-18 was expressed both in tissues and cell cultures. Expression of stem cell markers, such as CD44, Oct4 and Nanog, were also observed. Following differentiation with the glycogen synthase kinase 3β (GSK3β) inhibitor LiCl, the cells began to express E-cadherin and, at once, Twist1 and Snail expression was strongly downregulated, suggesting a MET-reverting process. In conclusion, we established primary colon mesenchymal cancer cell cultures expressing mesenchymal and epithelial biomarkers together with high level of EMT transcription factors. We propose that they could represent a good model for studying EMT and its reverting mechanism, the mesenchymal-to-epithelial transition (MET). Our observation indicates that LiCl, a GSK3β inhibitor, induces MET in vitro, suggesting that LiCl and GSK3β could represent, respectively, interesting drug, and target for CRC therapy.

AB - Epithelial-to-mesenchymal transition (EMT) confers stem cell-like phenotype and more motile properties to carcinoma cells. During EMT, the expression of E-cadherin decreases, resulting in loss of cell-cell adhesion and increased migration. Expression of Twist1 and other pleiotropic transcription factors, such as Snail, is known to activate EMT. We established primary colon cancer cell cultures from samples of operated patients and validated cultures by cytogenetic and molecular biology approaches. Western blot assay, quantitative real-time PCR and immunofluorescence were performed to investigate the expression of E-cadherin, vimentin, β-catenin, cytokeratin-20 and -18, Twist1, Snail, CD44, cyclooxygenase-2 (COX2), Sox2, Oct4 and Nanog. Moreover, cell differentiation was induced by incubation with LiCl-containing medium for 10 days. We observed that these primary colorectal cancer (CRC) cells lost expression of the E-cadherin epithelial marker, which was instead expressed in cancer and normal colon mucosa of the same patient, while overexpressed vimentin (mesenchymal marker), Twist1, Snail (EMT markers) and COX2. Cytokeratin-18 was expressed both in tissues and cell cultures. Expression of stem cell markers, such as CD44, Oct4 and Nanog, were also observed. Following differentiation with the glycogen synthase kinase 3β (GSK3β) inhibitor LiCl, the cells began to express E-cadherin and, at once, Twist1 and Snail expression was strongly downregulated, suggesting a MET-reverting process. In conclusion, we established primary colon mesenchymal cancer cell cultures expressing mesenchymal and epithelial biomarkers together with high level of EMT transcription factors. We propose that they could represent a good model for studying EMT and its reverting mechanism, the mesenchymal-to-epithelial transition (MET). Our observation indicates that LiCl, a GSK3β inhibitor, induces MET in vitro, suggesting that LiCl and GSK3β could represent, respectively, interesting drug, and target for CRC therapy.

KW - Colorectal cancer

KW - Epithelial-to-mesenchymal transition

KW - GSK3β inhibition

KW - Mesenchymal-to-epithelial transition

KW - Primary colon cancer cell cultures

KW - Stem cell-like phenotype

UR - http://www.scopus.com/inward/record.url?scp=84925424589&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84925424589&partnerID=8YFLogxK

U2 - 10.3892/ijo.2015.291

DO - 10.3892/ijo.2015.291

M3 - Article

AN - SCOPUS:84925424589

VL - 46

SP - 1913

EP - 1923

JO - International Journal of Oncology

JF - International Journal of Oncology

SN - 1019-6439

IS - 5

ER -